Daniel Bottomly

Also affiliated with OHSU Knight Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Discovery and characterization of targetable NTRK point mutations in hematologic neoplasms”.

Discovery and characterization of targetable NTRK point mutations in hematologic neoplasms

Blood(2020)10.1182/blood.2019003691

N/A

0DataRank · unranked

40 citations

Kristin Qian, William H. Bisson, Kevin Watanabe‐Smith, Ariane Huang, Daniel Bottomly +7 more

Mucin 4 Protects Female Mice from Coronavirus Pathogenesis

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.02.19.957118

N/A

0DataRank · unranked

18 citations

Kenneth S. Plante, Lisa E. Gralinski, Anne Beall, Martin T. Ferris, Daniel Bottomly +6 more

Modeling Host Genetic Regulation of Influenza Pathogenesis in the Collaborative Cross

UNC Libraries(2020)10.17615/epjv-w292

N/A

0DataRank · unranked

0 citations

Alan C. Whitmore, Shannon K. McWeeney, David L. Aylor, Timothy A. Bell, Lisa E. Gralinski +18 more

Expression Quantitative Trait Loci for Extreme Host Response to Influenza A in Pre-Collaborative Cross Mice

UNC Libraries(2020)10.17615/n0tk-5b74

N/A

0DataRank · unranked

0 citations

Daniel Bottomly, Elizabeth Rosenzweig, Bart L Haagmans, Birgit Bradel-Tretheway, Martin T. Ferris +11 more

Monocytic Differentiation and AHR Signaling as Primary Nodes of BET Inhibitor Response in Acute Myeloid Leukemia

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-21-0012

N/A

0DataRank · unranked

35 citations

Tamilla Nechiporuk, Daniel Bottomly, Sophia Jeng, Shannon K. McWeeney, Andy Kaempf +4 more

High dimensional mapping of temporal evolution within the marrow microenvironment in response to FLT3 inhibitor therapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.7020

N/A

0DataRank · unranked

0 citations

Sunil K. Joshi, Daniel Bottomly, Shannon K. McWeeney, Brian Druker, Evan Lind +2 more

Integrative analysis of drug response and clinical outcome in acute myeloid leukemia

Cancer Cell(2022)10.1016/j.ccell.2022.07.002

N/A

0DataRank · unranked

373 citations

Nicola Long, Anna Reister Schultz, Stephen E. Kurtz, Cristina E. Tognon, Kara Johnson +89 more

Dual BTK/SYK inhibition with CG-806 (luxeptinib) disrupts B-cell receptor and Bcl-2 signaling networks in mantle cell lymphoma

Cell Death and Disease(2022)10.1038/s41419-022-04684-1

N/A

0DataRank · unranked

26 citations

Tingting Liu, Nur Bruss, Carly Roleder, Vi Lam, Xiaoguang Wang +9 more

Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia

Molecular Cancer Research(2023)10.1158/1541-7786.mcr-22-0745

N/A

0DataRank · unranked

8 citations

Brittany M. Curtiss, Daniel J. Coleman, Jake VanCampen, Garth Kong, Jommel Macaraeg +10 more

Immune cell proportions correlate with clinicogenomic features and ex vivo drug responses in acute myeloid leukemia

Frontiers in Oncology(2023)10.3389/fonc.2023.1192829

N/A

0DataRank · unranked

1 citations

Daniel Bottomly, William M. Yashar, Nicola Long, Matthew Viehdorfer, Shannon K. McWeeney +2 more

The TLK-ASF1 histone chaperone pathway plays a critical role in IL-1β–mediated AML progression

Blood(2024)10.1182/blood.2023022079

N/A

0DataRank · unranked

8 citations

Mona Mohammadhosseini, John McClatchy, Marina Villamor-Payà, Sophia Jeng, Daniel Bottomly +10 more

Just how transformative will AI/ML be for immuno-oncology?

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-007841

N/A

0DataRank · unranked

8 citations

Shannon K. McWeeney, Daniel Bottomly

Assessing individual head and neck squamous cell carcinoma patient response to therapy through integration of functional and genomic data

Scientific Reports(2025)10.1038/s41598-025-03111-7

N/A

0DataRank · unranked

1 citations

Chase Mathieson, Myles Vigoda, Sophia Jeng, Nathaniel Evans, Ashley N. Anderson +8 more

CDK4/6 inhibition overcomes venetoclax resistance mechanisms with enhanced combination activity in acute myeloid leukemia

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102526

N/A

0DataRank · unranked

1 citations

Jessica Gibbs, Kevin Watanabe‐Smith, Ariel H. Nguyen, Isabel Kenna, Karina Thiel-Klare +12 more

Utilizing cohort-level and individual networks to predict best response in patients with metastatic triple negative breast cancer

npj Precision Oncology(2025)10.1038/s41698-025-00959-w

N/A

0DataRank · unranked

0 citations

Christina Zheng, Allison Creason, Zahi Mitri, Gordon B. Mills, Shannon K. McWeeney +1 more

A Rapid Gene Expression Profiler Classifies AML Tumor Responsiveness to Standard Therapies

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.08.681215

N/A

0DataRank · unranked

0 citations

Christopher A. Eide, Andy Kaempf, Nicola Long, Alexandria Miller, Daniel Bottomly +8 more

m6a and NuRD complexes regulate monocytic differentiation and resistance to BCL2/BCL2L1 inhibitors in acute myeloid leukemia

Haematologica(2025)10.3324/haematol.2025.287972

N/A

0DataRank · unranked

0 citations

Karen Morris, Quinlan Morrow, Stephen E. Kurtz, Daniel Bottomly, Shannon K. McWeeney +5 more